The anticoagulant of choice during percutaneous coronary intervention (PCI) in women is not well established. ⋯ In women undergoing PCI, bivalirudin is associated with reduced risk of major bleeding and NACE compared with heparin especially when GPI is routinely used.
read on…
or not…